enow.com Web Search

  1. Ads

    related to: von willebrand' s treatment center

Search results

  1. Results from the WOW.Com Content Network
  2. A vet’s guide to Von Willebrand Disease in dogs - AOL

    www.aol.com/vet-guide-von-willebrand-disease...

    Type 1 von Willebrand Disease in dogs. Type 1 von Willebrand Disease is the most common type, and also the mildest. It occurs when dogs have a mild deficiency in all the proteins making up their ...

  3. Vonicog alfa - Wikipedia

    en.wikipedia.org/wiki/Vonicog_alfa

    Vonicog alfa, sold under the brand names Vonvendi and Veyvondi, is a medication used to control bleeding in adults with von Willebrand disease (an inherited bleeding disorder). [6] [5] [7] [8] It is a recombinant von Willebrand factor. [6] [5] The most common adverse reactions are generalized itching, vomiting, nausea, dizziness, and vertigo. [6]

  4. von Willebrand disease - Wikipedia

    en.wikipedia.org/wiki/Von_Willebrand_disease

    Von Willebrand disease (VWD) is the most common hereditary blood-clotting disorder in humans. An acquired form can sometimes result from other medical conditions. [1] It arises from a deficiency in the quality or quantity of von Willebrand factor (VWF), a multimeric protein that is required for platelet adhesion. It is known to affect several ...

  5. Desmopressin - Wikipedia

    en.wikipedia.org/wiki/Desmopressin

    Desmopressin (DDAVP) is usually the first line treatment for mild to moderate type 1 von Willebrand disease. [1] It is not recommended in severe disease or in those with abnormal factor VIII. [1] Usefulness in type 2A, 2M, or 2N von Willebrand disease is variable. [1] Generally not recommended in 2B and type 3 von Willebrand disease. [1]

  6. von Willebrand factor - Wikipedia

    en.wikipedia.org/wiki/Von_Willebrand_factor

    Von Willebrand factor (VWF) (German: [fɔn ˈvɪləbʁant]) is a blood glycoprotein that promotes primary hemostasis, specifically, platelet adhesion.It is deficient and/or defective in von Willebrand disease and is involved in many other diseases, including thrombotic thrombocytopenic purpura, Heyde's syndrome, and possibly hemolytic–uremic syndrome. [5]

  7. Hemolytic–uremic syndrome - Wikipedia

    en.wikipedia.org/wiki/Hemolytic–uremic_syndrome

    Von Willebrand described this disorder in 1926, distinguishing it from hemophilia. The disorder was named after him, becoming known as von Willebrand disease. The cause of the disease was later discovered to be a deficiency of a protein, now known as von Willebrand factor, that enables hemostasis.

  8. Vasopressin receptor 2 - Wikipedia

    en.wikipedia.org/wiki/Vasopressin_receptor_2

    554 12000 Ensembl ENSG00000126895 ENSMUSG00000031390 UniProt P30518 O88721 RefSeq (mRNA) NM_000054 NM_001146151 NM_001276298 NM_001276299 NM_019404 RefSeq (protein) NP_000045 NP_001139623 NP_001263227 NP_001263228 NP_062277 Location (UCSC) Chr X: 153.9 – 153.91 Mb Chr X: 72.94 – 72.94 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Vasopressin receptor 2 (V2R), or arginine ...

  9. Platelet storage pool deficiency - Wikipedia

    en.wikipedia.org/wiki/Platelet_storage_pool...

    Platelet storage pool deficiency is a family of clotting disorders characterized by deficient granules in platelets.Individuals with these disorders have too few or abnormally functioning alpha granules, delta granules, or both alpha and delta granules and are therefore unable to form effective clots, which leads to prolonged bleeding.

  1. Ads

    related to: von willebrand' s treatment center